ArticleMolecular psychiatry2026
Novel selective morpholine trace amine-associated receptor 1 partial agonists show promising preclinical effects for neuropsychiatric disorders and are well tolerated in healthy volunteers.
Céline Fournier et al.PubMed ↗Publisher ↗
No numbers read from the abstract.